Detalles de la búsqueda
1.
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
J Autoimmun
; 135: 102984, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621174
2.
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
BMC Infect Dis
; 23(1): 332, 2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198536
3.
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.
Ann Rheum Dis
; 81(12): 1757-1766, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36357161
4.
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.
Ann Rheum Dis
; 82(6): 883-885, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720583
5.
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study.
Lancet Rheumatol
; 4(5): e338-e350, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35317410
6.
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
Lancet Rheumatol
; 4(6): e417-e429, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35527808
Resultados
1 -
6
de 6
1
Próxima >
>>